These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 7282414)

  • 1. [Therapeutic trials in schizophrenia with dialysis. State of the art and one case study (author's transl)].
    Meurice E; Godon JP; Mathieu F
    Acta Psychiatr Belg; 1980; 80(4):436-44. PubMed ID: 7282414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hemodialysis in patients with chronic schizophrenia (author's transl)].
    Kissling W; Emrich HM; Fischler M; von Zerssen D; Riedhammer H; Edel HH
    Fortschr Neurol Psychiatr Grenzgeb; 1980 Jul; 48(7):393-400. PubMed ID: 6903554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Maintenance electroconvulsive therapy and treatment of refractory schizophrenia].
    Lévy-Rueff M; Jurgens A; Lôo H; Olié JP; Amado I
    Encephale; 2008 Oct; 34(5):526-33. PubMed ID: 19068343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The status of extracorporeal detoxication procedures as a therapy method in schizophrenia].
    Seidel M; Ernst K; Lindenau K
    Psychiatr Neurol Med Psychol (Leipz); 1981 Dec; 33(12):705-17. PubMed ID: 7335825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Haemodialysis and schizophrenia (author's transl)].
    Bourgeois M
    Encephale; 1980; 6(4):367-70. PubMed ID: 7439112
    [No Abstract]   [Full Text] [Related]  

  • 8. Ego-pathology, body experience, and body psychotherapy in chronic schizophrenia.
    Röhricht F; Papadopoulos N; Suzuki I; Priebe S
    Psychol Psychother; 2009 Mar; 82(Pt 1):19-30. PubMed ID: 18789189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pathological fractures of the femoral neck in hemodialyzed patients. Apropos of 26 cases].
    Hardy P; Benoit J; Donneaud B; Jehanno P; Lortat-Jacob A
    Rev Chir Orthop Reparatrice Appar Mot; 1994; 80(8):702-10. PubMed ID: 7638399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A meta-analysis and critical review of the effects of conventional neuroleptic treatment on cognition in schizophrenia: opening a closed book.
    Mishara AL; Goldberg TE
    Biol Psychiatry; 2004 May; 55(10):1013-22. PubMed ID: 15121486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis.
    Heinz J; Kropf S; Luley C; Dierkes J
    Am J Kidney Dis; 2009 Sep; 54(3):478-89. PubMed ID: 19359080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between a self-rated health question and mortality in young and old dialysis patients: a cohort study.
    Thong MS; Kaptein AA; Benyamini Y; Krediet RT; Boeschoten EW; Dekker FW;
    Am J Kidney Dis; 2008 Jul; 52(1):111-7. PubMed ID: 18511166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biochemical and immunological changes in schizophrenics receiving haemodialysis treatment (author's transl)].
    Petrácek E; Steinerová A; Polívková V
    Cas Lek Cesk; 1980 Mar; 119(12-13):360-5. PubMed ID: 7397727
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of monthly dose and regular dosing of intravenous active vitamin D use on mortality among patients undergoing hemodialysis.
    St Peter WL; Li S; Liu J; Gilbertson DT; Arneson TJ; Collins AJ
    Pharmacotherapy; 2009 Feb; 29(2):154-64. PubMed ID: 19170585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal amyloidosis followed more than 5 years: report of 12 cases.
    Kaaroud H; Boubaker K; Béji S; Abderrahim E; Moussa FB; Turki S; Goucha R; Hedri H; El Younsi F; Kheder A; Maiz HB
    Transplant Proc; 2004; 36(6):1796-8. PubMed ID: 15350480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperbaric oxygen therapy for calcific uremic arteriolopathy: a case series.
    Basile C; Montanaro A; Masi M; Pati G; De Maio P; Gismondi A
    J Nephrol; 2002; 15(6):676-80. PubMed ID: 12495283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive effects of protein restriction in patients with chronic kidney disease.
    Eyre S; Attman PO; Haraldsson B
    J Ren Nutr; 2008 May; 18(3):269-80. PubMed ID: 18410883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hemodialysis and the idea of detoxification of blood in the therapy of schizophrenia (author's transl)].
    Philipp M
    Fortschr Neurol Psychiatr Grenzgeb; 1979 Jan; 47(1):36-46. PubMed ID: 252474
    [No Abstract]   [Full Text] [Related]  

  • 19. Duration of end-stage renal disease and kidney transplant outcome.
    Goldfarb-Rumyantzev A; Hurdle JF; Scandling J; Wang Z; Baird B; Barenbaum L; Cheung AK
    Nephrol Dial Transplant; 2005 Jan; 20(1):167-75. PubMed ID: 15546892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of health-related quality of life in dialysis patients. Personal experience using questionnaire SF-36].
    Kusztal M; Nowak K; Magott-Procelewska M; Weyde W; Penar J
    Pol Merkur Lekarski; 2003 Feb; 14(80):113-7. PubMed ID: 12728668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.